INR 128.1
(14.76%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 138.02 Million INR | 4.83% |
2022 | 230.62 Million INR | 87.26% |
2021 | 123.16 Million INR | 12.01% |
2020 | 109.95 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 28.06 Million INR | -50.2% |
2023 Q2 | 66.08 Million INR | 14.97% |
2023 FY | 241.76 Million INR | 4.83% |
2023 Q4 | 56.34 Million INR | -8.92% |
2023 Q3 | 61.86 Million INR | -6.39% |
2023 Q1 | 57.47 Million INR | 2099.93% |
2022 FY | 230.62 Million INR | 87.26% |
2022 Q4 | -2.87 Million INR | -104.7% |
2022 Q3 | 61.2 Million INR | 50.02% |
2022 Q2 | 40.79 Million INR | 0.0% |
2021 FY | 123.16 Million INR | 12.01% |
2020 FY | 109.95 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | 76.197% |
Ind-Swift Limited | 946.56 Million INR | 85.418% |
Bajaj HealthCare Limited | 985.34 Million INR | 85.992% |
Sakar Healthcare Limited | 204.07 Million INR | 32.365% |
Aurobindo Pharma Limited | 55.65 Billion INR | 99.752% |
Innova Captab Limited | 931.03 Million INR | 85.175% |
Divi's Laboratories Limited | 14.17 Billion INR | 99.026% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 94.42% |
Morepen Laboratories Limited | 1.98 Billion INR | 93.055% |
Mankind Pharma Limited | 29.27 Billion INR | 99.528% |
Sequent Scientific Limited | 2.9 Billion INR | 95.243% |
Wanbury Limited | 978.96 Million INR | 85.901% |
Laurus Labs Limited | 11.9 Billion INR | 98.841% |
Nectar Lifesciences Limited | 932.7 Million INR | 85.201% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 98.814% |
Alembic Limited | 872.45 Million INR | 84.179% |
Hikal Limited | 4.46 Billion INR | 96.908% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 99.13% |
Neuland Laboratories Limited | 2.92 Billion INR | 95.289% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 99.067% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 99.706% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 93.729% |
Themis Medicare Limited | 1.12 Billion INR | 87.739% |
RPG Life Sciences Limited | 1.63 Billion INR | 91.56% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.89% |
Lupin Limited | 125.09 Billion INR | 99.89% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 93.408% |
Wockhardt Limited | 8.48 Billion INR | 98.372% |
Vaishali Pharma Limited | 84.02 Million INR | -64.264% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 95.51% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | 68.526% |
Jubilant Pharmova Limited | 14.45 Billion INR | 99.045% |
FDC Limited | 3.49 Billion INR | 96.056% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.856% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 66.533% |
Eris Lifesciences Limited | 4.94 Billion INR | 97.208% |
Venus Remedies Limited | 1.91 Billion INR | 92.797% |
ZIM Laboratories Limited | 1.01 Billion INR | 86.375% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 90.274% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -136.805% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 93.652% |
Shilpa Medicare Limited | 3.33 Billion INR | 95.86% |
Albert David Limited | 1.02 Billion INR | 86.549% |
Ajanta Pharma Limited | 30.46 Billion INR | 99.547% |
Hester Biosciences Limited | 908.84 Million INR | 84.813% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 90.16% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 94.596% |
Gufic Biosciences Limited | 1.18 Billion INR | 88.368% |
Windlas Biotech Limited | 1 Billion INR | 86.286% |
Procter & Gamble Health Limited | 2.99 Billion INR | 95.392% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -871.146% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | 14.917% |
Granules India Limited | 10.31 Billion INR | 98.662% |
Aarti Drugs Limited | 1.16 Billion INR | 88.177% |
Bal Pharma Limited | 555.62 Million INR | 75.158% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.58% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.91% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 87.15% |
Medicamen Biotech Limited | 335.16 Million INR | 58.818% |
Unichem Laboratories Limited | 6.72 Billion INR | 97.948% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | 69.703% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -1923.886% |
Orchid Pharma Limited | 800.77 Million INR | 82.763% |
Medico Remedies Limited | 59.67 Million INR | -131.301% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 93.502% |
Ipca Laboratories Limited | 18.98 Billion INR | 99.273% |
Brooks Laboratories Limited | 51.18 Million INR | -169.693% |
Syncom Formulations (India) Limited | 345.63 Million INR | 60.065% |
Piramal Enterprises Limited | 63.65 Billion INR | 99.783% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 99.356% |
NATCO Pharma Limited | 10.05 Billion INR | 98.628% |
Suven Life Sciences Limited | 109.75 Million INR | -25.767% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -199.049% |
Strides Pharma Science Limited | 9.16 Billion INR | 98.494% |
Indoco Remedies Limited | 12.06 Billion INR | 98.856% |
Alpa Laboratories Limited | 127.38 Million INR | -8.36% |
Lasa Supergenerics Limited | 291.17 Million INR | 52.596% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 95.514% |